Advanced Life Sciences Announces Appointment of Leading Academic Researcher to Board of Directors

Woodridge, Ill, May 21, 2001 - Advanced Life Sciences, Inc. announced today the appointment of Rosalie Sagraves, Pharm.D., FCCP, to its Board of Directors. Dr. Sagraves, a leading academic researcher, is Dean and Professor of the College of Pharmacy at the University of Illinois at Chicago.

"We are honored to have Dr. Sagraves join Advanced Life Sciences' Board of Directors," said Dr. Sharon W. Ayd, Chief Operating Officer of Advanced Life Sciences. "Rosalie Sagraves has been a strong advocate for the field of pharmacy. Her affiliation with the academic community will help us bridge the gap between drug discovery and commercialization as colleges of pharmacy are frequently sources of discovery compounds."

Dr. Sagraves is an authority on pediatric pharmacotherapy and women's health issues and received the Kappa Epsilon/Merck Vanguard award for women leaders in pharmacy. She is a fellow of the American Pharmaceutical Association and the American College of Clinical Pharmacy. Currently, she is President of AphA-APRS and is a member of the America Pharmaceutical Association Board of Trustees. Dr. Sagraves has authored over 60 articles and book chapters and 40 abstracts and is on the Editorial Board of Pharmacy Today and American Pharmacy.

Advanced Life Sciences, Inc., based in Woodridge, Illinois ( is a privately held, early-stage pharmaceutical technology development company that discovers and develops therapeutic compounds to fight infection, inflammation and cancer. The company bridges the gap between academic discoveries and pharmaceutical commercialization and focuses on conditions that have significant unmet medical needs in medium sized markets.

# # #